Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver.

Studies were carried out in mice utilizing inhibitors of several cell surface molecules to evaluate their relative roles in chylomicron remnant removal. Anti-LDL receptor antibody inhibited approximately 45% of rapid remnant removal from plasma, prolonged their half life (63 s to 115 s) and reduced hepatic uptake by 45%. Receptor-associated protein (RAP) (1 mg/mouse), a high affinity inhibitor of the LDL receptor-related protein (LRP) and a low affinity inhibitor of the LDL receptor decreased remnant removal approximately 55%, prolonged the half life from 63 s to 230 s, and reduced hepatic uptake by 70%. RAP, but not anti-LDL receptor antibody, inhibited splenic uptake. With both injected together, an incremental effect was seen; plasma removal decreased 60%, T1/2 increased to 290 s, and hepatic uptake decreased by 80%. Thus, it is likely that virtually all of the very rapid removal of remnants from the plasma by the liver requires the presence of at least one of these members of the LDL receptor family. Anti-hepatic lipase antibody caused a small but significant delay in remnant removal from plasma and a larger decrease in hepatic uptake (22.5%). It doubled adrenal uptake. The anti-hepatic lipase antibody was not additive with either the anti-LDL receptor antibody or RAP. Anti-rat hepatic lipase antibody did not inhibit lipolysis by mouse hepatic lipase, suggesting that lipolysis is not the way hepatic lipase enhances remnant uptake. Hepatic lipase bound to remnants to a greater degree than it bound to other lipoproteins. Together these data suggest that hepatic lipase may serve as a binding site for chylomicron remnants, thereby enhancing their affinity for the liver surface, and thus removal by the proteins of the LDL receptor family. Other molecules may also play a role in removal from the circulation under conditions where the LDL receptor family receptors are absent or occupied.

[1]  S. Armstrong,et al.  Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. deSilva,et al.  Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Mahley,et al.  Chylomicron Metabolism in Normal, Cholesterol-fed, and Watanabe Heritable Hyperlipidemic Rabbits , 1995, Journal of Biological Chemistry.

[4]  G. Rogers,et al.  Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis , 1995, Hepatology.

[5]  D. Strickland,et al.  The 39-kDa Receptor-associated Protein Modulates Lipoprotein Catabolism by Binding to LDL Receptors (*) , 1995, The Journal of Biological Chemistry.

[6]  R. Mahley,et al.  Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  N. Maeda,et al.  Hepatic clearance of chylomicron remnants in mice lacking apoprotein E. , 1994, Biochimica et biophysica acta.

[8]  A. Hofman,et al.  Postprandial Triglyceride Response in Young Adult Men and Familial Risk for Coronary Atherosclerosis , 1994, Annals of Internal Medicine.

[9]  I. Simpson,et al.  Low density lipoprotein receptors in rat adipose cells: subcellular localization and regulation by insulin. , 1994, Journal of lipid research.

[10]  T. Willnow,et al.  Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. , 1994, Science.

[11]  K. Orth,et al.  Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. , 1994, The Journal of biological chemistry.

[12]  N. Maeda,et al.  The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Havel,et al.  Effect of the 39-kDa receptor-associated protein on the hepatic uptake and endocytosis of chylomicron remnants and low density lipoproteins in the rat. , 1994, The Journal of biological chemistry.

[14]  M. Komaromy,et al.  Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. , 1994, Journal of lipid research.

[15]  S. Griglio,et al.  Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. , 1994, The Biochemical journal.

[16]  M. Farquhar,et al.  Functional domains of the receptor-associated protein (RAP). , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Havel,et al.  Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. , 1994, Journal of lipid research.

[18]  R. Havel Postprandial hyperlipidemia and remnant lipoproteins. , 1994, Current opinion in lipidology.

[19]  R. Mahley,et al.  Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. , 1994, The Journal of biological chemistry.

[20]  Sungshin Y. Choi,et al.  A comparison of the roles of the low density lipoprotein (LDL) receptor and the LDL receptor-related protein/alpha 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo. , 1993, The Journal of biological chemistry.

[21]  A. Cooper Hepatic Clearance of Plasma Chylomicron Remnants , 1992, Seminars in liver disease.

[22]  T. V. van Berkel,et al.  Distinct properties of the recognition sites for beta-very low density lipoprotein (remnant receptor) and alpha 2-macroglobulin (low density lipoprotein receptor-related protein) on rat parenchymal cells. , 1992, The Journal of biological chemistry.

[23]  B. Bihain,et al.  Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. , 1992, Biochemistry.

[24]  M. Brown,et al.  39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.

[25]  J. Borensztajn,et al.  Apoprotein-independent binding of chylomicron remnants to rat liver membranes. , 1991, The Biochemical journal.

[26]  L. Fong,et al.  Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. , 1991, The Journal of clinical investigation.

[27]  R. Mahley,et al.  Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.

[28]  M. Komaromy,et al.  Expression of rat hepatic lipase in heterologous systems: evidence for different sites for interface binding and catalysis. , 1991, Journal of lipid research.

[29]  J. Mamo,et al.  Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor. , 1991, The Biochemical journal.

[30]  F. Kraemer,et al.  ELISA measurement of LDL receptors. , 1990, Journal of lipid research.

[31]  H. Jansen,et al.  Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. , 1990, Biochimica et biophysica acta.

[32]  R. Mahley,et al.  Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. , 1989, The Journal of biological chemistry.

[33]  J. Ellsworth,et al.  Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acid. , 1988, Journal of lipid research.

[34]  G. Getz,et al.  Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids. , 1988, Journal of lipid research.

[35]  J. Ellsworth,et al.  Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. , 1987, The Journal of biological chemistry.

[36]  E. Wisse,et al.  The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse , 1985, Hepatology.

[37]  G. Barnard,et al.  Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis. , 1984, The Journal of clinical investigation.

[38]  D. Bilheimer,et al.  Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Little,et al.  Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. , 1982, Atherosclerosis.

[40]  J. Borensztajn,et al.  Hepatic uptake of phospholipid-depleted chylomicrons in vivo. Comparison with the uptake of chylomicron remnants. , 1981, The Biochemical journal.

[41]  P. Kris-Etherton,et al.  Studies on the etiology of the hyperlipemia in rats fed an atherogenic diet. , 1980, Journal of lipid research.

[42]  A. Cooper,et al.  Rates of removal and degradation of chylomicron remnants by isolated perfused rat liver. , 1978, Journal of lipid research.

[43]  R. Mahley,et al.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. , 1978, Biochemistry.

[44]  P. Nilsson-ehle,et al.  A stable, radioactive substrate emulsion for assay of lipoprotein lipase. , 1976, Journal of lipid research.

[45]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[46]  A. Cooper,et al.  Characterization of the estrogen-induced lipoprotein receptor of rat liver. , 1987, Journal of lipid research.